Dintsios, C. M., & Beinhauer, I. (2020). The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany. BMC.
Dyfyniad Arddull ChicagoDintsios, C. M., and I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
Dyfyniad MLADintsios, C. M., and I. Beinhauer. The Impact of Additive or Substitutive Clinical Study Design On the Negotiated Reimbursement for Oncology Pharmaceuticals After Early Benefit Assessment in Germany. BMC, 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.